A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia

Zeitschrift fur Gastroenterologie

Volumn 40, Issue 6, 2002, Pages 401-408

  Rosch W ^a   Vinson, B ^a   Sassin, I ^a  

^a North West Hospital   (Germany)

Author keywords

Cisapride; Functional dyspepsia; Iberogast ; Randomised trial; STW 5

Indexed keywords

ANGELICA ROOT; ANGELICAE RADIX EXTRACT; CARDUI MARIAE FRUCTUS EXTRACT; CARVI FRUCTUS EXTRACT; CHELIDONII HERBA EXTRACT; CISAPRIDE; HERBACEOUS AGENT; LIQUIRITIAE RADIX EXTRACT; MATRICARIAE FLOS EXTRACT; MELISSAE FOLIUM EXTRACT; PEPPERMINT; PLACEBO; PLANT EXTRACT; STW 5; STW 5 II; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ADULT; ARTICLE; CARDUI MARIAE FRUCTUS; CARVI FRUCTUS; CHELIDONII HERBA; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; GASTROINTESTINAL SYMPTOM; GERMANY; HERBAL MEDICINE; HUMAN; IBERIS AMARA; LIQUIRITIAE RADIX; MAJOR CLINICAL STUDY; MALE; MATRICARIAE FLOS; MEDICINAL PLANT; MELISSA OFFICINALIS; MENTHAE PIPERITAE; MULTICENTER STUDY; NAUSEA; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCORING SYSTEM; STOMACH MOTILITY; VERTIGO;

ADULT; AGED; CISAPRIDE; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; GASTROPARESIS; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 0036072175     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-32130     Document Type: Article

References (31)

1. Geographical differences in the prevalence of dyspepsia
2. Economics of Helicobacter pylori eradication therapy
3. The clinical course and prognostic determinants of non-ulcer dyspepsia: A literature review
4. The functional gastrointestinal disorders and the Rome II process. A multinational consensus document on functional gastrointestinal disorders
5. Functional gastroduodenal disorders
6. Functional dyspepsia
7. Eradication of helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia
8. USA: Cisaprid wird zurückgezogen
9. Wirksamkeit und verträglichkeit von Iberogast bei patienten mit gesicherter non ulcus dyspepsie
10. Ein phytotherapeutikum und seine modifizierte rezeptur bei funktioneller dyspepsie
11. A double-blind, randomized, placebo-controlled trial on the effects of a herbal preparation in patients with functional dyspepsia
12. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis?
13. Factors affecting short- and longterm outcome of a short therapeutic trial with cisapride in dyspeptic patients
14. Drug treatment of functional dyspepsia: A systematic analysis of trial methodology with recommendations for design of future trials
15. Identification of sub-groups of functional gastrointestinal disorders
16. Benefit of a herbal preparation in patients with irritable bowel syndrome: Results of a double-blind, randomized, placebo-controlled multicenter trial
17. The effect of cisapride on dysmotility-like functional dyspepsia: Reduction of the fasting and postprandial area, but not of the postprandial antral expansion
18. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: A double-blind, placebo-controlled study
19. Efficacy and tolerability of the herbal preparation Iberogast® in the therapy of functional dyspepsia
20. Anwenclungsbeobachtung zur wirksamkeit und verträglichkeit von Iberogast® in der therapie des Colon irritabile
21. Gastrointestinal motility with Iberogast®